Amlogenyx
About:
Amlogenyx is a novel gene therapeutics company that focuses on developing lysosome-based treatments for Alzheimer's disease.
Top Investors: Ultragenyx Pharmaceutical, GordonMD Global Investments
Description:
Amlogenyx is a novel gene therapeutics company that focuses on developing lysosome-based treatments for Alzheimer's disease. It is a spin-off from Ultragenyx Pharmaceutical.
Total Funding Amount:
$14M
Headquarters Location:
Somerville, Massachusetts, United States
Founded Date:
2023-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-08-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai